Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Salt Formation . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel industrial synthesis route for Tenofovir Disoproxil Fumarate ensuring high purity and cost efficiency for global pharmaceutical supply chains and procurement teams.
Patent CN110691771A reveals a stable maleate salt route for spirotetramat intermediates, offering superior selectivity and supply chain reliability for agrochemical manufacturing.
Novel salt-based refining method ensures 99.8% purity for Acotiamide. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical partners.
Patent CN102348691A details a high-yield process for quinolinone derivatives, replacing DMSO with xylene to drastically reduce impurities and enhance supply chain reliability for API manufacturing.
Patent CN1126732C reveals high-yield esterification technology. Reduces toxic solvents significantly. Enhances supply chain reliability for global pharmaceutical intermediates manufacturing.
Novel salt-formation method enhances yield and purity for tricyclohexyl phosphine. Reduces oxidation risks and offers cost-effective manufacturing for global supply chains.
Patent CN111943910B details a safe KHSO5 oxidation route for Dioxopromethazine Hydrochloride, offering high purity and cost-effective manufacturing for pharmaceutical supply chains.
Novel salt formation method ensures over 99 percent purity for Perampanel intermediate. Reduces impurities significantly for reliable pharmaceutical intermediate supply chains.
Patent CN1514836A reveals a novel one-pot method for oxabispiperidine besylates, eliminating anion exchange steps for cost-effective pharmaceutical intermediate manufacturing.
Patent CN113979877A details a novel salt-formation refining method for Efavirenz intermediates, offering superior purity and waste recovery for pharmaceutical supply chains.
Patent CN101143863B details a novel resolution method for (6S)-5-MTHF using alpha-phenylethylamine, offering high purity and reduced chloride contamination for pharmaceutical manufacturing.
Patent CN1036201C details a novel separation method for alpha-APM using organic carboxylic acids, ensuring high purity and yield for reliable food additive supply chains.
Novel mesylate salt formation improves purity and yield. Reduces dimer impurities. Ideal for scalable pharma manufacturing.
Patent CN116478087B enables high-purity sodium picosulfate intermediate production with improved yield and supply chain reliability for pharmaceutical manufacturing.
Patent CN100341850C details a novel chiral resolution method for demethylphencynonate salts, enabling >98% optical purity for anti-motion sickness API manufacturing with reduced costs.
Novel resolution method for S-indoline-2-carboxylic acid using amino acid esters. High purity, recyclable mother liquor, optimized for Perindopril synthesis.
Novel ester-based crystallization method for Betamethasone Sodium Phosphate ensuring high purity and easy drying. Optimized for commercial scale-up and supply chain reliability.
Patent CN102010327B details a cost-effective resolution method for S-(+)-Ketoprofen using a novel amine resolving agent, ensuring high optical purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN108101881B details a novel salt formation process for trabectedin intermediates, replacing difficult chromatography with crystallization for superior purity and supply chain stability.
Advanced chiral resolution technology for 2-heterocyclic dihydropyrimidines using binaphthol phosphate. Delivers >99% optical purity for scalable hepatitis B drug manufacturing.